The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,673.00
Bid: 1,674.00
Ask: 1,675.00
Change: 3.00 (0.18%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets boosted by earnings, Eurozone PMIs

Wed, 24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China.easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher after results or trading updates this morning. Meanwhile, figures from blue chips Daimler, Volvo and Alstom also impressed over in Europe.In economic data, the Eurozone purchasing managers' indices (PMIs) for both the services and manufacturing sectors beat expectations in July, pushing the composite PMI from 48.7 to 50.4, well ahead of the 49.1 consensus forecast. This was the best reading of private-sector activity in 18 months."Sure, unemployment remains frighteningly high, political instability keeps the market on its toes and deep austerity will be biting hard for some time, but services and manufacturing facets of the Eurozone economy are turning a page," said Market Strategist Ishaq Siddiqi from ETX Capital.Markets were also digesting comments from Goldman Sachs analysts who said they see a near 50% probability that the Monetary Policy Committee will modify its stance at the August meeting. The most likely change would be a cut in the Bank rate or remuneration rate on bank reserves, but additional quantitative easing looks less likely. Chinese data disappointsHSBC's flash China manufacturing PMI fell from 48.2 to 47.7 in July, missing expectations of no change. "Under normal circumstances, this would weigh heavily on investor sentiment and therefore risk assets, such as the European indices, however that is not the case this morning," said Market Analyst Craig Erlam from Alpari.Downside risks to growth were tempered yesterday by the country's Premier Li Keqiang who assured that the pace of expansion would not fall below the "bottom line" of 7.0% this year, indicating that any slowdown would be met with more stimulus."This should limit the short-term negativity surrounding poor Chinese data because it seems for now that growth is guaranteed to remain at these higher levels," Erlam said.FTSE 100: Updates from heavyweights impresseasyJet surged this morning after the budget airline achieved a 10.5% rise in third-quarter revenue to £1.14bn, bolstered by an increase in capacity and growth in revenue per seat. Chip designer ARM Holdings was also on the rise after delivering better-than-expected second-quarter sales and profits. The company also said that dollar revenues would be "at least in line" with market expectations.Food ingredients firm Tate & Lyle gained after saying that adjusted profits were in line with expectations in spite of tough weather conditions in the States in the first quarter.Foodservice and support services company Compass rose after saying expectations for the full year remain "positive and unchanged" following a strong third quarter.Kingfisher, the DIY retail group behind B&Q and Screwfix, said it is on track to hit expectations for the first half after a pick-up in activity in the second quarter, causing shares to rise.Pharmaceuticals giant GlaxoSmithKline was trading higher this morning ahead of its results out this afternoon.Exchange operator London Stock Exchange was subdued after going ex-dividend. Engineering and project management group AMEC was trading lower after HSBC downgraded the stock to 'neutral' and cut its target price from 1,200p to 1,130p.FTSE 100 - RiserseasyJet (EZJ) 1,439.00p +7.71%ARM Holdings (ARM) 940.50p +4.73%Glencore Xstrata (GLEN) 292.40p +3.43%Weir Group (WEIR) 2,173.00p +2.89%Tate & Lyle (TATE) 847.00p +2.85%International Consolidated Airlines Group SA (CDI) (IAG) 293.90p +2.80%Travis Perkins (TPK) 1,720.00p +2.69%Antofagasta (ANTO) 875.50p +2.16%Melrose Industries (MRO) 273.60p +1.90%TUI Travel (TT.) 371.00p +1.87%FTSE 100 - FallersMeggitt (MGGT) 538.00p -1.65%Croda International (CRDA) 2,421.00p -1.14%British Land Co (BLND) 610.00p -1.13%BG Group (BG.) 1,198.00p -1.03%Sage Group (SGE) 356.00p -0.84%Hammerson (HMSO) 533.50p -0.56%Amec (AMEC) 1,066.00p -0.56%Hargreaves Lansdown (HL.) 1,006.00p -0.40%Barclays (BARC) 320.45p -0.40%Fresnillo (FRES) 1,088.00p -0.28%FTSE 250 - RisersImagination Technologies Group (IMG) 269.20p +7.38%Wetherspoon (J.D.) (JDW) 708.00p +5.99%National Express Group (NEX) 259.00p +5.50%Hochschild Mining (HOC) 171.60p +4.63%Mitchells & Butlers (MAB) 433.30p +4.41%Bumi (BUMI) 225.00p +3.93%Premier Farnell (PFL) 228.40p +3.12%Dialight (DIA) 1,221.00p +3.04%Playtech (PTEC) 706.50p +2.39%St. Modwen Properties (SMP) 308.80p +2.18%FTSE 250 - FallersBeazley (BEZ) 215.90p -4.34%TalkTalk Telecom Group (TALK) 246.80p -2.06%Renishaw (RSW) 1,535.00p -2.04%Kier Group (KIE) 1,395.00p -1.97%Man Group (EMG) 86.15p -1.94%Chemring Group (CHG) 301.00p -1.67%Carpetright (CPR) 666.00p -1.62%Great Portland Estates (GPOR) 577.50p -1.45%Anite (AIE) 130.00p -1.44%Barr (A.G.) (BAG) 562.00p -1.23%BC
More News
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.